Procedures-550 US alpaca owners, stratified by state and randomly selected from a list of approximately 4,300 owners, were mailed a study description, voluntary participation request, and questionnaire. Thirty-nine owners submitted blood samples from up to 6 alpacas > 6 months old; 27 of 39 owners submitted another blood sample from the same alpacas > 1 month later. Samples were tested for serum virus-neutralizing antibodies against BVDV. Seropositive status was used to indicate BVDV exposure. Associations between seropositive status and potential risk factors for BVDV exposure described in questionnaires were evaluated by use of a Fisher exact test.
Results-8 of 192 (4.2%) alpacas in 3 of 39 (7.7%) herds were seropositive. Larger herds had a greater percentage of seropositive alpacas than did smaller herds. No alpaca from which a second blood sample was obtained seroconverted during 292 to 1,460 alpaca-days (mean, 740 alpaca-days) of potential exposure. 
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